Wade G W & Inc. Has $11.96 Million Holdings in CVS Health Corp (CVS)

Wade G W & Inc. raised its holdings in CVS Health Corp (NYSE:CVS) by 1.6% in the third quarter, Holdings Channel reports. The fund owned 151,906 shares of the pharmacy operator’s stock after acquiring an additional 2,416 shares during the quarter. CVS Health makes up about 1.3% of Wade G W & Inc.’s investment portfolio, making the stock its 25th largest position. Wade G W & Inc.’s holdings in CVS Health were worth $11,958,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of CVS. Cornerstone Wealth Management LLC raised its stake in shares of CVS Health by 7,112.7% in the 2nd quarter. Cornerstone Wealth Management LLC now owns 336,183 shares of the pharmacy operator’s stock valued at $5,158,000 after acquiring an additional 331,522 shares during the period. Sumitomo Life Insurance Co. raised its stake in shares of CVS Health by 4.5% in the 2nd quarter. Sumitomo Life Insurance Co. now owns 23,089 shares of the pharmacy operator’s stock valued at $1,486,000 after acquiring an additional 991 shares during the period. Baldwin Brothers Inc. MA raised its stake in shares of CVS Health by 152.7% in the 2nd quarter. Baldwin Brothers Inc. MA now owns 7,861 shares of the pharmacy operator’s stock valued at $506,000 after acquiring an additional 4,750 shares during the period. Cribstone Capital Management LLC raised its stake in shares of CVS Health by 9.5% in the 2nd quarter. Cribstone Capital Management LLC now owns 27,270 shares of the pharmacy operator’s stock valued at $1,755,000 after acquiring an additional 2,366 shares during the period. Finally, Foster & Motley Inc. raised its stake in shares of CVS Health by 24.7% in the 2nd quarter. Foster & Motley Inc. now owns 45,623 shares of the pharmacy operator’s stock valued at $2,936,000 after acquiring an additional 9,031 shares during the period. Hedge funds and other institutional investors own 83.03% of the company’s stock.

In other news, EVP Eva C. Boratto sold 13,311 shares of CVS Health stock in a transaction dated Monday, September 17th. The shares were sold at an average price of $77.16, for a total value of $1,027,076.76. Following the completion of the transaction, the executive vice president now directly owns 55,162 shares of the company’s stock, valued at approximately $4,256,299.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Lisa Bisaccia sold 21,534 shares of CVS Health stock in a transaction dated Monday, October 1st. The shares were sold at an average price of $80.00, for a total transaction of $1,722,720.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 57,638 shares of company stock valued at $4,558,875. 0.53% of the stock is owned by company insiders.

Shares of CVS stock opened at $75.09 on Friday. The firm has a market cap of $76.50 billion, a price-to-earnings ratio of 12.73, a P/E/G ratio of 1.00 and a beta of 0.98. The company has a quick ratio of 1.94, a current ratio of 2.44 and a debt-to-equity ratio of 1.66. CVS Health Corp has a 1-year low of $60.14 and a 1-year high of $83.88.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Tuesday, November 6th. The pharmacy operator reported $1.73 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.71 by $0.02. The company had revenue of $47.27 billion during the quarter, compared to analyst estimates of $47.22 billion. CVS Health had a net margin of 1.65% and a return on equity of 18.69%. The firm’s revenue for the quarter was up 2.4% compared to the same quarter last year. During the same period last year, the business earned $1.50 EPS. Equities analysts forecast that CVS Health Corp will post 7.03 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Thursday, November 1st. Shareholders of record on Wednesday, October 24th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.66%. The ex-dividend date of this dividend was Tuesday, October 23rd. CVS Health’s dividend payout ratio is currently 33.90%.

CVS has been the topic of a number of research reports. ValuEngine raised shares of CVS Health from a “sell” rating to a “hold” rating in a research note on Tuesday, November 6th. Bank of America raised their target price on shares of CVS Health from $86.00 to $90.00 and gave the company a “buy” rating in a research note on Monday, September 17th. Royal Bank of Canada reissued a “buy” rating and issued a $90.00 target price on shares of CVS Health in a research note on Wednesday, August 8th. Loop Capital set a $80.00 target price on shares of CVS Health and gave the company a “hold” rating in a research note on Friday, November 9th. Finally, Argus raised their target price on shares of CVS Health to $100.00 and gave the company a “buy” rating in a research note on Tuesday, November 13th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, eleven have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $90.04.

TRADEMARK VIOLATION NOTICE: This report was originally reported by WKRB News and is owned by of WKRB News. If you are accessing this report on another site, it was stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this report can be accessed at https://www.wkrb13.com/2018/11/23/wade-g-w-inc-has-11-96-million-holdings-in-cvs-health-corp-cvs.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Featured Article: Index Funds

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply